4885
MUROMACHI CHEMICALS INC.
室町ケミカル
- Industry
- Pharmaceutical
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Non-consolidated
Key metrics
Revenue(thousand JPY)
May 2021
4,942,963
May 2022
5,681,099
May 2023
6,291,379
May 2024
6,369,097
May 2025
6,653,028
Operating profit(thousand JPY)
May 2021
369,336
May 2022
437,341
May 2023
369,413
May 2024
421,837
May 2025
432,188
Operating profit margin(%)
May 2021
7.47
May 2022
7.7
May 2023
5.87
May 2024
6.62
May 2025
6.5
Profit before tax(thousand JPY)
May 2021
199,616
May 2022
425,603
May 2023
350,900
May 2024
468,586
May 2025
350,048
Profit(thousand JPY)
May 2021
180,714
May 2022
456,272
May 2023
256,302
May 2024
330,197
May 2025
241,277
Total assets(thousand JPY)
May 2021
4,612,324
May 2022
4,798,071
May 2023
4,948,311
May 2024
5,059,267
May 2025
5,264,574
Cash and cash equivalents(thousand JPY)
May 2021
1,000,373
May 2022
865,361
May 2023
852,606
May 2024
1,050,427
May 2025
1,028,068
Cash flows from operating activities(thousand JPY)
May 2021
487,669
May 2022
524,905
May 2023
317,189
May 2024
637,701
May 2025
215,961
Cash flows from investing activities(thousand JPY)
May 2021
-57,734
May 2022
-176,280
May 2023
-162,408
May 2024
-232,230
May 2025
-370,504
Cash flows from financing activities(thousand JPY)
May 2021
-310,512
May 2022
-483,635
May 2023
-172,390
May 2024
-209,954
May 2025
123,200
Return on equity(%)
May 2021
22.8
May 2022
30.3
May 2023
14.3
May 2024
15.8
May 2025
10.2
Equity ratio(%)
May 2021
28.9
May 2022
35
May 2023
38.7
May 2024
44.9
May 2025
46.6
Earnings per share(JPY per share)
May 2021
65.24
May 2022
123.79
May 2023
67.94
May 2024
83.42
May 2025
60.42
Net assets per share(JPY per share)
May 2021
363.93
May 2022
450.37
May 2023
487.25
May 2024
571.26
May 2025
612.4
Dividend per share(JPY per share)
May 2021
15
May 2022
19
May 2023
19
May 2024
22
May 2025
25
Payout ratio(%)
May 2021
22.99
May 2022
15.35
May 2023
27.97
May 2024
26.37
May 2025
41.38
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.